BRIEF-Aegerion Pharmaceuticals issues $325 mln aggregate principal amount of 2.00% convertible senior notes

* Entered into a supplemental indenture to indenture dated August 15, 2014 -SEC filing
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.